Diabetes & EndocrinologyGLP-1 receptor agonistneovascular age-related macular degeneration
Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study
By MedXY|Jun 10, 2026
In a large OHDSI network study of adults with type 2 diabetes, semaglutide was not associated with a higher or lower risk of neovascular age-related macular degeneration.
